Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 8;26(1):51.
doi: 10.1186/s40001-021-00524-8.

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

SeyedAhmad SeyedAlinaghi  1 , Pegah Mirzapour  1 , Omid Dadras  2 , Zahra Pashaei  3 , Amirali Karimi  4 , Mehrzad MohsseniPour  1 , Mahdi Soleymanzadeh  5 , Alireza Barzegary  6 , Amir Masoud Afsahi  7 , Farzin Vahedi  4 , Ahmadreza Shamsabadi  8 , Farzane Behnezhad  9 , Solmaz Saeidi  10 , Esmaeil Mehraeen  11 , Shayesteh Jahanfar  12
Affiliations

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

SeyedAhmad SeyedAlinaghi et al. Eur J Med Res. .

Abstract

Introduction: Coronavirus Disease-2019 (SARS-CoV-2) started its devastating trajectory into a global pandemic in Wuhan, China, in December 2019. Ever since, several variants of SARS-CoV-2 have been identified. In the present review, we aimed to characterize the different variants of SARS-CoV-2 and explore the related morbidity and mortality.

Methods: A systematic review including the current evidence related to different variants of SARS-CoV-2 and the related morbidity and mortality was conducted through a systematic search utilizing the keywords in the online databases including Scopus, PubMed, Web of Science, and Science Direct; we retrieved all related papers and reports published in English from December 2019 to September 2020.

Results: A review of identified articles has shown three main genomic variants, including type A, type B, and type C. we also identified three clades including S, V, and G. Studies have demonstrated that the C14408T and A23403G alterations in the Nsp12 and S proteins are the most prominent alterations in the world, leading to life-threatening mutations.The spike D614G amino acid change has become the most common variant since December 2019. From missense mutations found from Gujarat SARS-CoV-2 genomes, C28854T, deleterious mutation in the nucleocapsid (N) gene was significantly associated with patients' mortality. The other significant deleterious variant (G25563T) is found in patients located in Orf3a and has a potential role in viral pathogenesis.

Conclusion: Overall, researchers identified several SARS-CoV-2 variants changing clinical manifestations and increasing the transmissibility, morbidity, and mortality of COVID-19. This should be considered in current practice and interventions to combat the pandemic and prevent related morbidity and mortality.

Keywords: COVID-19; Characterizations; Genomic diversity; SARS-CoV-2; Strains; Variants.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interests regarding the publication of this manuscript.

References

    1. Esmaeil M, Farzane B, Mohammad AS, Tayebeh N, Hamid H, SeyedAhmad S. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19) a review of current evidence. Eur Arch Oto-Rhino-Laryngol. 2020 doi: 10.1007/s00405-020-06120-6. - DOI - PMC - PubMed
    1. Mehraeen E, Hayati B, Saeidi S, Heydari M, Seyed AS. Self-care instructions for people not requiring hospitalization for coronavirus disease 2019 (COVID-19) Arch Clin Infect Dis. 2020 doi: 10.5812/archcid.102978. - DOI
    1. De Vito A, Fiore V, Princic E, Geremia N, Panu Napodano CM, Muredda AA, et al. Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes. PLoS ONE. 2021;16(3):e0248009–e. doi: 10.1371/journal.pone.0248009. - DOI - PMC - PubMed
    1. De Vito A, Fau GN, Fiore V, Fau FV, Princic E, Fau PE, Babudieri S, Fau BS, Madeddu G, Madeddu G. Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia Italy. Eur Rev Med Pharmacol Sci. 2020;24(14):7861–8. - PubMed
    1. Vaira LA-OX, Deiana G, Fois AG, Pirina P, Madeddu G, De Vito A, et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: single–center experience on 72 cases. Head neack. 2020;42:1252–8. doi: 10.1002/hed.26204. - DOI - PMC - PubMed

Publication types

Substances